These findings suggest that GABBR2 may play a protective role in AD by modulating the non-amyloidogenic pathway of APP processing, which is mediated by ADAM10, thereby reducing the amyloidogenic pathway that involves BACE1. The gene discussed is APP; the disease is Alzheimer disease.